SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Offer Update

3 Jun 2008 07:00

RNS Number : 7987V
Mentor Graphics Corporation
03 June 2008
 



Not for release, publication or distribution, in whole or in part, in or into or from the United StatesCanada or Australia or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction

CASH OFFER

for

FLOMERICS GROUP PLC

by

MENTOR GRAPHICS CORPORATION

Offer Update

In his letter to Flomerics Shareholders dated 30 May 2008, the Chairman and Chief Executive Officer of Mentor stated: "In the letter and accompanying document sent to you by your Chairman on 27 May 2008, Flomerics portrayed a superficially attractive picture, both regarding the current trading of Flomerics and its valuation. However, I wish to remind you that as well as acquiring a substantial number of shares from institutional investors at 104 pence per share, Mentor also acquired 20.1 per cent. of Flomerics share capital from Pricap, a sophisticated financial institution active in this market. Pricap also had a representative on the Board of Flomerics and, therefore, was in a position to make an informed decision as to the fair value of a Flomerics Share. I continue to believe that our cash offer is an attractive one to all shareholders."

Mentor has been asked by the Panel Executive to clarify that the decision by Pricap to sell its Flomerics Shares to Mentor, which was announced on 14 March 2008, was taken solely on the basis of publicly available information and was taken without any input from and without the knowledge of Wolfgang Biedermann, the individual that Mentor considered to be a representative of Pricap on the Flomerics Board.

Enquiries:

Mentor

Dennis Weldon

Ryerson Schwark Tel: +1 503 685 7000

Cenkos Securities plc 

Nicholas Wells  Tel: +44 20 7397 8900

Bell Pottinger Corporate & Financial

David Rydell

Olly Scott Tel: +44 20 7861 3232

 

Definitions used in the Offer Document dated 17 May 2008 have the same meaning when used in this announcement, unless the context requires otherwise. 

This press announcement does not constitute an offer or invitation to purchase any securities or a solicitation of an offer to purchase any securities, pursuant to the Offer or otherwise. The Offer is being made solely by means of the Offer Document and, in the case of Flomerics Shares held in certificated form, the accompanying Form of Acceptance which contains the full terms and conditions of the Offer, including details of how the Offer may be accepted. 

 

Dealing disclosure requirements

Under the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the 'City Code'), if any person is, or becomes, 'interested' (directly or indirectly) in one per cent. or more of any class of 'relevant securities' of Flomerics, all 'dealings' in any 'relevant securities' of Flomerics (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30 pm (London time) on the London Business Day following the date of the relevant transaction. This requirement will continue until the date on which the Offer becomes, or is declared, unconditional as to acceptance, lapses or is otherwise withdrawn or on which the 'offer period' otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Flomerics they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the City Code, all 'dealings' in 'relevant securities' of Flomerics by Mentor or Flomerics or by any of their respective 'associates', must be disclosed by no later than 12.00 noon (London time) on the London Business Day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk.

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the City Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPFKBKPCBKDBAK
Date   Source Headline
31st Jan 20197:00 amRNSTrading Update & Notice of Full Year Results
29th Jan 20197:00 amRNSHolding(s) in Company
23rd Jan 20199:42 amRNSChange of Registered Office
27th Nov 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSDeferred Consideration and Total Voting Rights
23rd Oct 20187:00 amRNSTrading update - nine month period ended 30.9.18
12th Oct 201812:07 pmRNSSecond Price Monitoring Extn
12th Oct 201812:02 pmRNSPrice Monitoring Extension
2nd Oct 20187:00 amRNSHolding(s) in Company
1st Oct 20183:03 pmRNS2018 Half-year Report Published
27th Sep 201812:06 pmRNSDirector/PDMR Shareholding
24th Sep 201810:02 amRNSDirector/PDMR Shareholding
20th Sep 20186:04 pmRNSDirector/PDMR Shareholding
20th Sep 20181:20 pmRNSDirector/PDMR Shareholding
18th Sep 20187:01 amRNSHalf-year Report
18th Sep 20187:00 amRNSDirectorate Changes
24th Aug 20181:57 pmRNSHolding(s) in Company- updated
23rd Aug 20183:53 pmRNSHolding(s) in Company
24th Jul 20186:24 pmRNSDirector/PDMR Shareholding
17th Jul 20187:00 amRNSGroup Trading Update & Notice of HY Results
6th Jun 201811:10 amRNSResult of AGM
6th Jun 20187:00 amRNSAGM Statement
21st May 20183:46 pmRNSHolding(s) in Company
14th May 20187:00 amRNSOption Exercise and Director's Dealings
4th May 20183:30 pmRNS2017 Annual Report - year ended 31 December 2017
27th Apr 20185:51 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSHolding(s) in Company
17th Apr 20187:01 amRNSQ1 2018 Quarter Results
17th Apr 20187:00 amRNSFinal statement of results - year ended 31.12.17
9th Apr 201811:35 amRNSHolding(s) in Company
3rd Apr 201811:24 amRNSResult of General Meeting & Total Voting Rights
26th Mar 201812:18 pmRNSHolding(s) in Company
23rd Mar 20187:00 amRNSFlowtech Chairman receives FTSE AIM NED award
20th Mar 20183:16 pmRNSCompletion of the acquisition of Balu Limited
19th Mar 20182:39 pmRNSHolding(s) in Company
19th Mar 201811:52 amRNSOption Exercise and Director's Dealings
15th Mar 20187:00 amRNSPosting of circular
14th Mar 20187:00 amRNSAcquisition of Balu Ltd - Placing to raise £11m
1st Mar 201812:03 pmRNSHolding(s) in Company
26th Feb 201812:51 pmRNSHolding(s) in Company
23rd Jan 20187:00 amRNS2017 Trading Update & Notice of Full-Year Results
19th Oct 20171:54 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSQ3 Group Trading Update
12th Oct 20177:00 amRNSAcquisition of Group HES, New Division established
27th Sep 20173:57 pmRNSSilver award winner for 2017 online Annual Report
22nd Sep 20172:48 pmRNSHolding(s) in Company
19th Sep 20176:36 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSOrganic & acquisition strategy underpins future
7th Sep 20173:38 pmRNSFLOWTECH EXPANDS ITS FOOTPRINT IN EUROPE
10th Jul 20177:00 amRNSGroup Trading update & Notice of HY results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.